RxDoctor Payments Data

Lauren Lea

Family · Arlington Heights, ILNPI 1720644297

Payments from drug & device makers

$3,108in general payments, 2019–2025

Across 103 payments — averaging $30.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$843
  • Boehringer Ingelheim$534
  • Novartis$483
  • Kestra Medical Technology Services, Inc.$225
  • E.r. Squibb & Sons, L.L.C.$160
  • Shockwave Medical, Inc$151
  • plus $712 from 11 others

What the payments were for

  • Food & beverage$3,05898%
  • Education$502%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,108 in reported general payments places this provider in the 90th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Medicare billing

Part B allowed, 2024
$4,896
Medicare patients
56
Services billed
75

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban48$37,484
JardianceEmpagliflozin41$29,924
EntrestoSacubitril/Valsartan22$20,449
FarxigaDapagliflozin Propanediol29$18,434
XareltoRivaroxaban11$13,601
Metoprolol Succinate111$1,324
Spironolactone134$761
Bumetanide29$686
Torsemide21$597
Furosemide116$399
Atorvastatin Calcium33$343
ClopidogrelClopidogrel Bisulfate19$258
Losartan Potassium52$222
Carvedilol26$146
Warfarin Sodium14$111

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$34$37,48448 claims
Boehringer IngelheimJardiance$534$29,92441 claims
NovartisEntresto$483$20,44922 claims
AstraZenecaFarxiga$59$18,43429 claims
Johnson & JohnsonXarelto$25$13,60111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,941 family providers in Illinois.

Other family in Arlington Heights

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →